Fibroblasts and asthma

The symptoms of bronchial asthma relate to airways obstruction which may be either episodic or chronic. Pharmacological [1,2] and. more recently, pathological studies [3,4] have demonstrated the inadequacy of the simple model of IgE-mediated mast cell degranulation as an explanation of the complexities of bronchial asthma. In particular, immunopathological studies have demonstrated that the airway inflammation previotisly associated with fatal asthma occurs during life in mild asthma. Pathological studies of bronchial biopsy specimens have confirmed the apparent thickening ofthe bronchial epithelial basement membrane [5,6] which was previously reported in autopsy studies of fatal acute severe asthma [7,8]. It is now evident that this phenomenon occurs in mild atopic asthma even with a relatively short clinical history. This characteristic appearance had been ascribed previously to chronic epithelial cell damage, leading to the synthesis of new basement membrane components, akin to the microvaseular damage in diabetes mellitus [9]. This view had persisted, despite ultrastructural studies which had shown that the true epithelial basement membrane was normal and that the apparent thickening was due to the deposition of fibrillar collagen species leading to an increase in the depth and density of the lamina reticularis [6.10], which lies beneath the basement membrane proper (Fig. 1). Further sludies in larger numbers of patients have confirmed that this abnormal layer in asthma is composed of interstitial collagens [4,11]. A detailed immunohistochemical study has shown that collagens III and V and, to a lesser extent collagen I, contribute to this thickening and that the epithelial basement membrane components, collagen IV and Iaminin. are absent [II]. These findings indicate that this layer is composed of the structural collagens of mesenchymal connective tissue. The presence of these interstitial components has led to a search for a mesenchymal celi that might secrete collagens beneath the epithelial basement membrane in asthma. An analogy

[1]  J. Schrader,et al.  Connective tissue mast cells in contact with fibroblasts express IL-3 mRNA. Analysis of single cells by polymerase chain reaction. , 1991, Journal of immunology.

[2]  J. Koopmans Bronchial inflammation and asthma treatment , 1991, The Lancet.

[3]  E. Kovacs Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. , 1991, Immunology today.

[4]  E. Leonard,et al.  Human monocyte chemoattractant protein-1 (MCP-1). , 1990, Immunology today.

[5]  M. Jordana,et al.  Neutrophilic differentiation induced by human upper airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF). , 1991, American journal of respiratory cell and molecular biology.

[6]  P. Howarth,et al.  Myofibroblasts and subepithelial fibrosis in bronchial asthma. , 1990, American journal of respiratory cell and molecular biology.

[7]  J. Tavernier,et al.  Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony- stimulating factor , 1990, The Journal of experimental medicine.

[8]  K. Nocka,et al.  Candidate ligand for the c‐kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. , 1990, The EMBO journal.

[9]  R. Djukanović,et al.  Mucosal inflammation in asthma. , 1990, The American review of respiratory disease.

[10]  J. Zubeldia,et al.  Murine eosinophils and IL-1: alpha IL-1 mRNA detection by in situ hybridization. Production and release of IL-1 from peritoneal eosinophils. , 1990, Journal of immunology.

[11]  A. Wardlaw,et al.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. , 1989, The American review of respiratory disease.

[12]  R. Coffman,et al.  Interleukin‐6 , 1989 .

[13]  W. Paul,et al.  Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores , 1989, Nature.

[14]  J. Denburg,et al.  Basophil mast cell and eosinophil growth and differentiation factors in human allergic disease , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[16]  S. Holgate,et al.  SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.

[17]  S. Holgate,et al.  Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.

[18]  J. Adamson,et al.  Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation. , 1988, The Journal of clinical investigation.

[19]  W. Bodmer,et al.  Colonic pericrypt sheath cells: characterisation of cell type with new monoclonal antibody. , 1987, Journal of clinical pathology.

[20]  D. Cockcroft,et al.  Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. , 1987, The Journal of allergy and clinical immunology.

[21]  A. Woolcock,et al.  Rate of decline of lung function in subjects with asthma. , 1987, European journal of respiratory diseases.

[22]  K. Austen,et al.  Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Dinarello,et al.  Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. , 1986, The Journal of clinical investigation.

[24]  E. Shaffer,et al.  Collagenous colitis: A disease of pericryptal fibroblast sheath? , 1986, The Journal of pathology.

[25]  H. Sluiter,et al.  Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. , 1985, The Journal of allergy and clinical immunology.

[26]  Roche Wr Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. , 1985 .

[27]  W. Roche Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. , 1985, The American journal of pathology.

[28]  P. Amenta,et al.  The basement membrane in pathology. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[29]  S. Kusumoto,et al.  Stimulating effect of MDP and its adjuvant-active analogues on guinea pig fibroblasts for the production of thymocyte-activating factor , 1983, The Journal of experimental medicine.

[30]  K. Norrby Mast cell histamine, a local mitogen acting via H2-receptors in nearby tissue cells , 1980, Virchows Archiv. B, Cell pathology including molecular pathology.

[31]  J. Delâge,et al.  Immunopathology of the bronchial mucosa in ‘late onset’ asthma , 1977, Clinical allergy.

[32]  I. Gery,et al.  Immunoglobulin E antibodies to milk proteins , 1971 .

[33]  R. Pascal,et al.  Colonic pericryptal fibroblast sheath: replication, migration, and cytodifferentiation of a mesenchymal cell system in adult tissue. I. Autoradiographic studies of normal rabbit colon. , 1968, Gastroenterology.

[34]  G. Salvato Some histological changes in chronic bronchitis and asthma , 1968, Thorax.

[35]  M. Dunnill THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSA , 1960, Journal of clinical pathology.

[36]  J. Trounce,et al.  A Clinical and Pathological Study of Fatal Cases of Status Asthmaticus , 1953, Thorax.